Table 1.

Patient characteristics

Clinicopathological features	No. of patients	P value
		DFS	miR-34a	miR-34b	miR-34c	miR-31	miR-192	miR-215
Age (years)		0.378	0.503	0.452	0.621	0.257	0.343	0.250
≤55	43 (53.8%)
>55	37 (46.2%)
Gender		0.364	0.593	0.143	0.221	0.689	0.506	0.477
Male	46 (57.5%)
Female	34 (42.5%)
Anatomic location		0.435	0.407	0.217	0.230	0.241	0.121	0.730
Tibia/femur	59 (73.8%)
Elsewhere	21 (26.2%)
Tumor size (cm)		0045*	0. 025*	0.348	0.022*	0.101	0.237	0.049*
≤8	50 (62.5%)
>8	30 (37.5%)
Clinical stage		0.003*	0.045*	0.204	0.272	0.067	0.371	0.769
IIA	19 (23.8%)
IIB/III	61 (76.2%)
Distant metastasis		0.004*	0. 990	0.125	0.103	0.034*	0.283	0.106
Negative	31 (38.8%)
Positive	49 (61.2%)
Response to chemotherapy		0.037*	0.098	0.190	0.337	0.308	0.018*	0.031*
Good	33 (41.3%)
Poor	47 (58.7%)
P53 expression		0.001*	0.078	0.194	0.451	0.154	0.012*	0.046*
High	20 (25.0%)
Low	60 (75.0%)